Vaxcyte, Inc. PCVX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$320.62M-30.1% | -$246.51M-15.8% | -$212.83M-27.8% | -$166.57M-18.4% | -$140.72M-2.7% | ||
| $2.95M-60.7% | $7.5M+145% | $3.06M+6.4% | $2.88M-2.6% | $2.96M+3.2% | ||
| $37.96M+5.5% | $36M+2.0% | $35.31M-4.4% | $36.93M+20.6% | $30.62M+25.6% | ||
| -$280.63M-24.8% | -$224.83M-56.9% | -$143.31M-18.3% | -$121.17M+27.1% | -$166.27M-49.3% | ||
| $2.11M-20.6% | $2.65M-30.6% | $3.82M+111% | $1.81M-66.6% | $5.42M+34.9% | ||
| -$233.41M-303% | $115.13M-5.0% | $121.17M+55.9% | $77.74M-37.0% | $123.32M+122% | ||
| $601.58M+24,883% | $2.41M+166% | -$3.67M-246% | $2.52M+232% | $759K-84.5% | ||
| $86.88M+181% | -$107.12M-320% | -$25.52M+36.4% | -$40.11M+2.2% | -$41.03M+93.8% | ||
| -$282.73M-24.3% | -$227.49M-54.6% | -$147.13M-19.6% | -$122.98M+28.4% | -$171.7M-48.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Vaxcyte, Inc. generate?
- Vaxcyte, Inc. (PCVX) generated -$769.9M in operating cash flow over the trailing twelve months.
- What is Vaxcyte, Inc.'s free cash flow?
- After $10.4M of capital expenditures, Vaxcyte, Inc.'s free cash flow was -$780.3M over the trailing twelve months, down 61.9% year over year.
- Where does Vaxcyte, Inc.'s cash flow data come from?
- Every line is extracted from Vaxcyte, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.